These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 27701410)

  • 1. Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer's disease.
    Jiao SS; Shen LL; Zhu C; Bu XL; Liu YH; Liu CH; Yao XQ; Zhang LL; Zhou HD; Walker DG; Tan J; Götz J; Zhou XF; Wang YJ
    Transl Psychiatry; 2016 Oct; 6(10):e907. PubMed ID: 27701410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease.
    Rosa E; Mahendram S; Ke YD; Ittner LM; Ginsberg SD; Fahnestock M
    Neurobiol Aging; 2016 Dec; 48():135-142. PubMed ID: 27676333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
    Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro validation of effects of BDNF-expressing mesenchymal stem cells on neurodegeneration in primary cultured neurons of APP/PS1 mice.
    Song MS; Learman CR; Ahn KC; Baker GB; Kippe J; Field EM; Dunbar GL
    Neuroscience; 2015 Oct; 307():37-50. PubMed ID: 26297896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective brain-derived neurotrophic factor signaling in the TAU-P301L tauopathy zebrafish model.
    Barbereau C; Yehya A; Silhol M; Cubedo N; Verdier JM; Maurice T; Rossel M
    Pharmacol Res; 2020 Aug; 158():104865. PubMed ID: 32417505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased pro-nerve growth factor and decreased brain-derived neurotrophic factor in non-Alzheimer's disease tauopathies.
    Belrose JC; Masoudi R; Michalski B; Fahnestock M
    Neurobiol Aging; 2014 Apr; 35(4):926-33. PubMed ID: 24112788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal BDNF expression in a tau transgenic mouse model.
    Burnouf S; Belarbi K; Troquier L; Derisbourg M; Demeyer D; Leboucher A; Laurent C; Hamdane M; Buee L; Blum D
    Curr Alzheimer Res; 2012 May; 9(4):406-10. PubMed ID: 22272617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model.
    Lee ST; Chu K; Jung KH; Kim JH; Huh JY; Yoon H; Park DK; Lim JY; Kim JM; Jeon D; Ryu H; Lee SK; Kim M; Roh JK
    Ann Neurol; 2012 Aug; 72(2):269-77. PubMed ID: 22926857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. proBDNF Accelerates Brain Amyloid-β Deposition and Learning and Memory Impairment in APPswePS1dE9 Transgenic Mice.
    Chen J; Zhang T; Jiao S; Zhou X; Zhong J; Wang Y; Liu J; Deng J; Wang S; Xu Z
    J Alzheimers Dis; 2017; 59(3):941-949. PubMed ID: 28697556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model.
    Burnouf S; Martire A; Derisbourg M; Laurent C; Belarbi K; Leboucher A; Fernandez-Gomez FJ; Troquier L; Eddarkaoui S; Grosjean ME; Demeyer D; Muhr-Tailleux A; Buisson A; Sergeant N; Hamdane M; Humez S; Popoli P; Buée L; Blum D
    Aging Cell; 2013 Feb; 12(1):11-23. PubMed ID: 23082852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer's disease-like pathologies in APP/PS1 transgenic mice.
    Wang QH; Wang YR; Zhang T; Jiao SS; Liu YH; Zeng F; Li J; Yao XQ; Zhou HD; Zhou XF; Wang YJ
    J Neurochem; 2016 Jul; 138(1):163-73. PubMed ID: 26991827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage.
    Shibuya Y; Niu Z; Bryleva EY; Harris BT; Murphy SR; Kheirollah A; Bowen ZD; Chang CCY; Chang TY
    Neurobiol Aging; 2015 Jul; 36(7):2248-2259. PubMed ID: 25930235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotrophin receptor p75 mediates amyloid β-induced tau pathology.
    Shen LL; Li WW; Xu YL; Gao SH; Xu MY; Bu XL; Liu YH; Wang J; Zhu J; Zeng F; Yao XQ; Gao CY; Xu ZQ; Zhou XF; Wang YJ
    Neurobiol Dis; 2019 Dec; 132():104567. PubMed ID: 31394202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation on the Role of BDNF in the Benefits of Blueberry Extracts for the Improvement of Learning and Memory in Alzheimer's Disease Mouse Model.
    Tan L; Yang H; Pang W; Li H; Liu W; Sun S; Song N; Zhang W; Jiang Y
    J Alzheimers Dis; 2017; 56(2):629-640. PubMed ID: 28035919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A small-molecule microtubule-stabilizing agent safely reduces Aβ plaque and tau pathology in transgenic mouse models of Alzheimer's disease.
    Yao Y; Muench M; Alle T; Zhang B; Lucero B; Perez-Tremble R; McGrosso D; Newman M; Gonzalez DJ; Lee VM; Ballatore C; Brunden KR
    Alzheimers Dement; 2024 Jul; 20(7):4540-4558. PubMed ID: 38884283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy.
    Siman R; Cocca R; Dong Y
    PLoS One; 2015; 10(11):e0142340. PubMed ID: 26540269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.